Newland Pharmaceutical Co Ltd Sustainability Reports
Newland Pharmaceutical Co., Ltd. develops, produces, and sells chiral pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Its products include the L-p-hydroxyphenylglycine series and p-toluenesulfonic acid used in medicine production.
Sector: Manufacturing
Country: China
Exchange: Shenzhen Stock Exchange
FIGI: BBG001TYFB37
3 reports from 2022 to 2024
